Advocating for those with Hep C Here and Abroad

AdvocatingThis fall, Daryl Luster, hep C advocate and president of PHCN, will be advocating for those with hepatitis C and their support networks here and abroad. The following is a list of the meetings that Daryl is looking forward to being a part of:

October 13-14 — Toronto, Ontario
Action Hepatitis Canada (AHC) Advocacy Meeting
Action Hepatitis Canada is a group that unites organizations and individuals to advocate for increased attention for hepatitis B and C–diseases that negatively affect the quality of life of up to 600,000 Canadians and support networks.
At the meeting Daryl and Cheryl Reitz, from HepC BC, will speak on hep C advocacy in BC.

October 20 — Windsor, England
Advocacy Meeting Sponsored by AbbVie
This meeting will bring together clinicians, policy, and NGO experts from around the world who are working for hepatitis policy change and development. The meeting will examine the World Health Organization’s HCV action plan and will be facilitated by Dr. Rafael Bengoa from the Health Policy program at the Duesto Business School in Spain. Dr. Bengoa develops strategies/action plans for fighting hepatitis and has successfully implemented them in both Spain and Israel.
At this meeting, Action Hepatitis Canada will be represented by two of its executives, Jeff Potts and Daryl Luster. Daryl may be the only person representing those with hep C who has had the disease.

October 21 — Ottawa, Ontario, via webcam
Canadian Institutes of Health Research (CIHR) Lecture
CIHR is the Government of Canada’s health research investment agency. Its mandate is to build scientific knowledge and to translation it into improved health, more effective health services and products, and a strong Canadian health care system.
Daryl has been invited to speak to CIHR about advocacy as a member of CanHepC, a new group formed to address hep C issues in Canada.

November 11 – 12 — Vancouver, BC
The Hepatitis Cure & Eradication Meeting
The Hepatitis Cure & Eradication Meeting will gather hepatitis experts from different disciplines to learn how science can influence public policy to work to cure and eliminate hepatitis.
Daryl will be one of the meeting’s speakers. He will talk about his role as a hep C advocate who has also been a patient.

“I’m not a lone voice, I’m many and our voices are our most powerful weapons.” Malala Yousafzai